Linked Life Data

11920188

Source:http://linkedlifedata.com/resource/pubmed/id/11920188

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-3-28
pubmed:abstractText
Recently, a report has suggested the efficacy and safety of thalidomide in refractory multiple myeloma. In an attempt to assess the efficacy and tolerance of thalidomide in advanced multiple myeloma (on behalf of the Intergroupe Franchophone dy Myelome (IFM)), we report the preliminary experience of the IFM with this drug.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1466-4860
pubmed:author
pubmed:issnType
Print
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-9
pubmed:dateRevised
2007-7-20
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Thalidomide in patients with advanced multiple myeloma.
pubmed:affiliation
Service des Maladies du Sang, CHU, Lille, France.
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study